Daiichi Sankyo Europe highlights need to address the perception and classification of CVD risk with data presentations at EAS 2022
Latest data from the SANTORINI disease registry show that the cardiovascular (CV) risk of hypercholesterolaemia patients was underestimated considerably in the clinical setting.1,2,3 SANTORINI data show that nearly 80% of patients who are at high-risk or very high-risk of CV events do not attain guideline recommended low-density lipoprotein cholesterol (LDL-C) goals.1,2,3 Study data further demonstrates … [Read more…]
